Published on: 2026-06-09
Source: People’s Republic of China in Russian –
An important disclaimer is at the bottom of this article.
Beijing, June 9 /Xinhua/ — Chinese authorities are launching a nationwide campaign to combat corruption and other illegal activities in the procurement and distribution of pharmaceutical products, as well as in the medical services sector. This step will become part of the broad effort by the PRC government to improve governance in these sectors and to maintain public trust in the medical sector.
Recently, the State Committee for Healthcare Affairs (GKDZ), together with 13 other specialized agencies, issued a circular outlining the key tasks to eliminate abuses both in the field of pharmaceutical distribution and in the area of medical services in 2026, according to the GKDZ press release published.
There are a total of 11 main tasks in the circular, in particular, the authorities have promised to take measures against such crimes as acts of violence against medical workers and online harassment aimed at healthcare institutions.
Among other tasks is combating illegal marketing practices disguised as academic or research activities, as well as violations in the field of aesthetic medicine, including unlicensed services, unauthorized short-term training courses, and false commercial advertising.
In addition, the circular also specifies tasks to prevent illegal surrogacy services, identify the place of the fetus, and issue counterfeit birth certificates.
In the pharmaceutical product recall sector, the circular notes that regulatory authorities must focus their efforts on investigating such violations as the absence of clear price labeling, price fraud, and collusion aimed at manipulating drug prices.
The document also requires tightening oversight of the procurement of expensive medical consumables and medical equipment. Authorities focus attention on violations such as unlawful interference by key decision-makers in the procurement processes, splitting projects to avoid public tenders, as well as individual technical tasks for tenders.
In addition, the circular contains calls for stricter adherence to professional ethics standards by medical personnel and rules for combating corruption in medical institutions, including clinics affiliated with universities.
Please note; this information is raw content, obtained directly from the information source. It represents an accurate report of what the source asserts and does not necessarily reflect the position of MIL-OSI or its clients.